Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV001094294 | SCV000399153 | uncertain significance | Primary ciliary dyskinesia 13 | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
Invitae | RCV000271707 | SCV000561286 | likely benign | Primary ciliary dyskinesia | 2023-11-10 | criteria provided, single submitter | clinical testing | |
Ce |
RCV002275012 | SCV002563355 | likely benign | not provided | 2022-07-01 | criteria provided, single submitter | clinical testing | DNAAF1: BP4, BP7 |
Ambry Genetics | RCV000271707 | SCV002727371 | uncertain significance | Primary ciliary dyskinesia | 2022-09-01 | criteria provided, single submitter | clinical testing | The c.1083C>T variant (also known as p.G361G), located in coding exon 8 of the DNAAF1 gene, results from a C to T substitution at nucleotide position 1083. This nucleotide substitution does not change the glycine at codon 361. This nucleotide position is poorly conserved in available vertebrate species. In silico splice site analysis for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |